Related Experiment Video
Updated: May 29, 2026

04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
Germ cell tumour: late recurrence after 43 years
Annals of the Royal College of Surgeons of England
|September 28, 2011
Summary
Late relapse of testicular germ cell tumors is possible, even after 43 years. This case highlights the need for extended surveillance beyond current guidelines for these rare occurrences.
Area of Science:
- Oncology
- Urology
- Pathology
Background:
- Testicular germ cell tumors (GCTs) are the most common solid malignancy in young men.
- Current European Association of Urology guidelines recommend at least five years of surveillance for GCTs due to high relapse rates.
- The optimal duration for long-term follow-up remains unclear.
Observation:
- A patient with a suspected pure seminoma, which showed yolk sac differentiation, experienced a relapse 43 years after initial diagnosis and treatment.
- This represents the longest documented time to relapse for a GCT, significantly exceeding the previously recorded 32 years for malignant teratoma with de-differentiation.
Findings:
- This case report confirms that late relapse of testicular germ cell tumors can occur, irrespective of the initial stage or type.
- The observed 43-year surveillance period underscores the potential for GCTs to remain dormant for decades before relapsing.
Implications:
- Extended surveillance protocols for testicular germ cell tumors may be warranted, potentially beyond the standard five-year recommendation.
- Further research is needed to establish definitive long-term follow-up guidelines for GCT survivors to account for exceptionally late relapses.
- This case emphasizes the importance of lifelong vigilance in managing patients treated for GCTs.
Related Concept Videos
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...